Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Three mega-cap names set the tone this week. Netflix reports Monday after the bell. General Motors follows Tuesday morning, and Tesla closes the day Tuesday after the bell. German car registration data tracked by ORTEX leads GM revenue by 15 days. That series ran 133% above year-ago levels across all three months of Q3. The same dataset leads Tesla revenue by 43 days and ran 269% above the same period last year. Both readings point in the same direction heading into the prints. Options flow is split: Tesla's RSI sits at 42.2, reflecting some caution, while GM carries heavy positioning on both sides.
Wall Street split cleanly along sector lines today. and both received upgrades. Palantir joined them. Three cybersecurity and AI upgrades in a single session signals growing confidence ahead of Q4 IT budgets. Utilities went the other way. and were both downgraded. was also cut, bucking the usual bullish tone around asset managers.
Chewy short interest hit 91.2% of free float, up more than 25 percentage points in seven days. That is one of the sharpest single-week moves in US mid-to-large cap stocks. Crypto miners MARA, Riot Platforms, and CleanSpark are also drawing short sellers as borrow conditions tighten.
On the EV side, real-economy data tells a different story. Malaysian battery-electric car registrations jumped 69% year-on-year in September to 5,945 units. European EV registrations rose 40% over the same month. Both readings strengthen the backdrop for Tesla and European automakers heading into earnings season.
Tomorrow's MSCI World ranking cut-off is a key risk event. Fabrinet's deletion probability moved from 8% to 49% overnight according to ORTEX Index Rebalance Radar. A deletion would force an estimated $826M of selling. Zalando and Xero also sit near their exit lines, with $357M and $393M of potential selling at stake respectively.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.